The Brookings Institution recently held a panel discussion of key questions around comparative effectiveness research.  Senate Finance Committee Chair Max Baucus (D-Mont.) and Office of Management and Budget (OMB) Director Peter Orszag offered opening comments. Participants discussed the importance of comparative effectiveness research to overall health care reform for lowering costs, eliminating variation in spending and quality of care, and promoting measurement and benchmarking.

Citing the recent JAMA article underscoring our desire and need to enlarge the evidence base for ACC/AHA guidelines, panelists noted that comparative effectiveness research could help develop more robust guideline evidence in the future.

Meanwhile, ACC’s new policy position on comparative effectiveness and clinical effectiveness research is due to be disseminated and published soon!

*** Image from Flickr (Leo Reynolds). ***

< Back to Listings